📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: TargeGen

1.1 - Company Overview

TargeGen Logo

TargeGen

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of vascular biology-focused small molecule kinase inhibitors targeting vascular leakage (edema), vascular proliferation (angiogenesis), and inflammation, offering treatments for human diseases such as heart attack, cancer, and eye diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to TargeGen

Sagimet Biosciences Logo

Sagimet Biosciences

HQ: United States Website
  • Description: Provider of novel therapeutics targeting FASN, including Denifanstat, an oral, once-daily selective FASN inhibitor in development for MASH, acne, and certain cancers, and TVB-3567, a pipeline FASN inhibitor planned for U.S. clinical development for acne.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sagimet Biosciences company profile →
Anji Pharma Logo

Anji Pharma

HQ: United States Website
  • Description: Provider of therapeutics targeting high-value, human genetics-validated targets, including ANJ900, a gut-targeted formulation of metformin for type 2 diabetes patients with advanced chronic kidney disease to lower glucose with reduced systemic exposure, and ANJ908 (Pradigastat), a DGAT1 inhibitor for chronic idiopathic constipation to increase bowel movement frequency and soften stool.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Anji Pharma company profile →
LEAF Pharmaceuticals Logo

LEAF Pharmaceuticals

HQ: United States Website
  • Description: Provider of biotechnology and healthcare products, including investigational anticancer drugs targeting solid tumors (LEAF-1401, LEAF-1701) with preclinical results showing reduced metastatic tumor burden in lung cancer models, superior performance in colorectal models, and minimal myelosuppression and gastrointestinal toxicity, plus LEAF-1404, a complex generic anticancer medicine manufactured under global cGMP.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LEAF Pharmaceuticals company profile →
Apotheca Biosciences Logo

Apotheca Biosciences

HQ: United States Website
  • Description: Provider of cutting-edge medical products, nutraceuticals, and formulation and delivery technologies for the healthcare and consumer care industry, including transdermal, sublingual, and nasal delivery technologies for precise, controlled dosing of cannabinoids.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Apotheca Biosciences company profile →
Arena Pharmaceuticals Logo

Arena Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical research and development focused on cardiovascular, central nervous system, inflammatory, and metabolic diseases, including the development of lorcaserin hydrochloride, which has reported positive clinical trial data. Headquartered in San Diego, CA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arena Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for TargeGen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to TargeGen

2.2 - Growth funds investing in similar companies to TargeGen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for TargeGen

4.2 - Public trading comparable groups for TargeGen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to TargeGen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About TargeGen

What does TargeGen do?

TargeGen is a provider of vascular biology-focused small molecule kinase inhibitors targeting vascular leakage (edema), vascular proliferation (angiogenesis), and inflammation, offering treatments for human diseases such as heart attack, cancer, and eye diseases.

Who are TargeGen's competitors?

TargeGen's competitors and similar companies include Sagimet Biosciences, Anji Pharma, LEAF Pharmaceuticals, Apotheca Biosciences, and Arena Pharmaceuticals.

Where is TargeGen headquartered?

TargeGen is headquartered in United States.

How many employees does TargeGen have?

TargeGen has 1,000 employees 🔒.

When was TargeGen founded?

TargeGen was founded in 2010 🔒.

What sector and industry vertical is TargeGen in?

TargeGen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for TargeGen

Who are the top strategic acquirers in TargeGen's sector and industry

Top strategic M&A buyers and acquirers in TargeGen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for TargeGen?

Top strategic M&A buyers groups and sectors for TargeGen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in TargeGen's sector and industry vertical

Which are the top PE firms investing in TargeGen's sector and industry vertical?

Top PE firms investing in TargeGen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in TargeGen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in TargeGen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in TargeGen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to TargeGen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in TargeGen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for TargeGen?

The key public trading comparables and valuation benchmarks for TargeGen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for TargeGen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for TargeGen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in TargeGen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for TargeGen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in TargeGen's' sector and industry vertical?

Access recent funding rounds and capital raises in TargeGen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for TargeGen